Cargando…

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology

Iron is an essential micronutrient for a myriad of physiological processes in the body beyond erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF), with a prevalence reaching up to 59% even in non-anaemic patients. ID impairs exercise capacity, reduces the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alnuwaysir, Ridha I. S., Hoes, Martijn F., van Veldhuisen, Dirk J., van der Meer, Peter, Beverborg, Niels Grote
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745653/ https://www.ncbi.nlm.nih.gov/pubmed/35011874 http://dx.doi.org/10.3390/jcm11010125

Ejemplares similares

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
por: Bomer, Nils, et al.
Publicado: (2022)

Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study
por: Alnuwaysir, Ridha I.S., et al.
Publicado: (2021)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use
por: van der Wal, Haye H, et al.
Publicado: (2019)

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function
por: Hoes, Martijn F., et al.
Publicado: (2018)

Selenium and outcome in heart failure
por: Bomer, Nils, et al.
Publicado: (2019)

A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure
por: Al-Mubarak, Ali A., et al.
Publicado: (2020)

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
por: Hoes, Martijn F., et al.
Publicado: (2019)

Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View
por: Dams, Olivier C., et al.
Publicado: (2022)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del
por: Deiman, Frederik E., et al.
Publicado: (2022)

High selenium levels associate with reduced risk of mortality and new‐onset heart failure: data from PREVEND
por: Al‐Mubarak, Ali A., et al.
Publicado: (2022)

Pathophysiological pathways in patients with heart failure and atrial fibrillation( )
por: Santema, Bernadet T, et al.
Publicado: (2021)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)
por: Ponikowski, Piotr, et al.
Publicado: (2015)

Iron deficiency in heart failure
por: Loncar, Goran, et al.
Publicado: (2021)

Treatment of Iron Deficiency in Heart Failure
por: Shamsi, Aamir, et al.
Publicado: (2023)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
por: Sindone, Andrew, et al.
Publicado: (2022)

An Erythropoietin-Independent Mechanism of Erythrocytic Precursor Proliferation Underlies Hypoxia Tolerance in Sea Nomads
por: Ilardo, Melissa, et al.
Publicado: (2022)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
por: Sama, Iziah E., et al.
Publicado: (2020)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment
por: Nauta, Jan F., et al.
Publicado: (2019)

Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

The role of iron deficiency in heart failure
por: Caminiti, Giuseppe, et al.
Publicado: (2023)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice
por: McDonagh, Theresa, et al.
Publicado: (2018)

Cancer and heart disease: associations and relations
por: de Boer, Rudolf A., et al.
Publicado: (2019)

Acute heart failure and iron deficiency: a prospective, multicentre, observational study
por: van Dalen, Dirk H., et al.
Publicado: (2021)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

Iron Deficiency in Acute Decompensated Heart Failure
por: Beale, Anna, et al.
Publicado: (2019)

Iron Deficiency in Heart Failure: Characteristics and Treatment
por: Martin, Ryan C, et al.
Publicado: (2021)

Iron Deficiency in Patients with Advanced Heart Failure
por: Bakosova, Maria, et al.
Publicado: (2022)

Iron Deficiency in Korean Patients With Heart Failure
por: Park, Jin Joo, et al.
Publicado: (2023)

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
por: Tromp, Jasper, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_627s5t0kic3av6cnh7gct40p77